pwRMSrelapsing multiple sclerosisofatumumabteriflunomideOMB-OMB
…er support long-term safety and efficacy data for ofatumumab in pwRMS, including RDTN pwRMS, informing clinical decision-making.…
4articles mentioning diseases
9disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: PwRMS ×
PwRMS
This disease is selected. Its supporting articles are shown below.
Articles mentioning PwRMS
4 articles · page 1 of 1pwRMSrelapsing multiple sclerosisCOVID-19frexalimabfrexalimab1200mgfrexalimab300mgNCT04879628
…avourable safety and sustained reduction in disease activity in pwRMS through W96, supporting its further development in phase-3 tria…
PwRMSPw) relapsing and primary progressive multiple sclerosisocrelizumabOCR
…eurofilament light chain (sNfL) level. In OCARINA II, OCR-naive PwRMS/PPMS patients were randomized to OCR IV or SC, and all later re…
77.8%
COVID-19appendicitisUTIherpes viral infectionspwRMSofatumumabOMB
….84%) had 130 SIs over 6 years. Most commonly reported SIs were COVID-19 (n=49; 2.49%), UTI (n=16; 0.81%), lower RTI (n=16; 0.81%), and …